Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Trial Investigating Ustekinumab for Systemic Lupus Erythematosus Discontinued
Tacrolimus Inhalation Powder Gets Orphan Drug Status for Organ Rejection Prophylaxis
Long-Term Rituximab May Aid in Antibody-Associated Vasculitis
FDA Grants Orphan Drug Status to Antifibrotic Therapy for Systemic Sclerosis
Voclosporin NDA for Lupus Nephritis Submitted to FDA
Trial Evaluating Ruxolitinib for COVID-19 Associated Cytokine Storm Initiated
Telitacicept Fast-Tracked for Systemic Lupus Erythematosus
Patient’s Death Leads to Lawsuit After Physician Fails to Check Creatinine Level Before Infusing Drug
Remestemcel-L Under Review for Steroid-Refractory Acute Graft Versus Host Disease
FDA: Insulin Among Drugs Transitioned to Biological Products
Certain Blister Packages of Sandimmune, Neoral Not Child Resistant
The FDA Approval Process Needs Refinement, Not a Total Overhaul
Anifrolumab Improves Response at 52 Weeks in Lupus
Belimumab Associated With Meaningful Improvement in Lupus Nephritis Trial
Xembify Now Available for Primary Humoral Immunodeficiency
Itolizumab Receives Fast Track Status for Lupus Nephritis
Voclosporin Superior to Standard of Care in Lupus Nephritis Trial
Palmoplantar Pustulosis Confirmed as Orphan Disease
